Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer

World Journal of Gastroenterology ◽

10.3748/wjg.v22.i2.887 ◽

2016 ◽

Vol 22 (2) ◽

pp. 887 ◽

Author(s):

Akiko Kubo

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Skin Toxicity ◽

Antibody Treatment ◽

Receptor Antibody ◽

Epidermal Growth

Download Full-text

Association between serum ligands and the skin toxicity of anti‐epidermal growth factor receptor antibody in metastatic colorectal cancer

Cancer Science ◽

10.1111/cas.12642 ◽

2015 ◽

Vol 106 (5) ◽

pp. 604-610 ◽

Author(s):

Naoki Takahashi ◽

Yasuhide Yamada ◽

Koh Furuta ◽

Kengo Nagashima ◽

Akiko Kubo ◽

...

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Skin Toxicity ◽

Receptor Antibody ◽

Epidermal Growth

Download Full-text

Panitumumab, a Monoclonal Anti–Epidermal Growth Factor Receptor Antibody in Colorectal Cancer: Another One or the One?: Table 1.

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-0065 ◽

2007 ◽

Vol 13 (16) ◽

pp. 4664-4666 ◽

Author(s):

Wells A. Messersmith ◽

Manuel Hidalgo

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Receptor Antibody ◽

Epidermal Growth ◽

Download Full-text

Biomarkers for Predicting the Efficacy of Anti-Epidermal Growth Factor Receptor Antibody in the Treatment of Colorectal Cancer

Digestion ◽

10.1159/000356202 ◽

2014 ◽

Vol 89 (1) ◽

pp. 18-23 ◽

Author(s):

Yasuyuki Okada ◽

Hiroshi Miyamoto ◽

Takahiro Goji ◽

Tetsuji Takayama

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Receptor Antibody ◽

Epidermal Growth

Download Full-text

Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2211-0 ◽

2013 ◽

Vol 72 (2) ◽

pp. 397-403 ◽

Author(s):

David Tougeron ◽

Ulrich Cortes ◽

Aurélie Ferru ◽

Claire Villalva ◽

Christine Silvain ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Antibody Treatment ◽

Kras Mutations ◽

Monoclonal Antibody Treatment ◽

Epidermal Growth

Download Full-text

Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer

Anticancer Research ◽

10.21873/anticanres.12101 ◽

2017 ◽

Vol 37 (11) ◽

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Receptor Antibody ◽

Epidermal Growth

Download Full-text

BEACON CRC study safety lead-in: Assessment of the BRAF inhibitor encorafenib + MEK inhibitor binimetinib + anti–epidermal growth factor receptor antibody cetuximab for BRAFV600E metastatic colorectal cancer

Annals of Oncology ◽

10.1093/annonc/mdy149.026 ◽

2018 ◽

Vol 29 ◽

pp. v109 ◽

Author(s):

E. Van Cutsem ◽

P. Cuyle ◽

S. Huijberts ◽

J. Schellens ◽

E. Elez ◽

...

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Braf Inhibitor ◽

Mek Inhibitor ◽

Receptor Antibody ◽

Epidermal Growth

Download Full-text

CETUXIMAB (ERBITUX®), AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER

Target Validation in Drug Discovery ◽

10.1016/b978-012369393-8/50004-3 ◽

2007 ◽

pp. 43-67

Author(s):

ZHENPING ZHU

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Receptor Antibody ◽

Epidermal Growth

Download Full-text

Recent Results and Ongoing Trials with Panitumumab (ABXEGF), a Fully Human Anti–Epidermal Growth Factor Receptor Antibody, in Metastatic Colorectal Cancer

Clinical Colorectal Cancer ◽

10.1016/s1533-0028(11)70161-x ◽

2005 ◽

Vol 5 (1) ◽

pp. 21-23 ◽

Author(s):

Preeta Tyagi ◽

Edward Chu ◽

Vinay K. Jain

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Receptor Antibody ◽

Epidermal Growth

Download Full-text

Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer

Recent Patents on Anti-Cancer Drug Discovery ◽

10.2174/1574209199544168928 ◽

2009 ◽

Vol 999 (999) ◽

pp. 1-8

Author(s):

Anne Kendall ◽

Rosemary Lord ◽

Nick Maisey

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Antibodies

Download Full-text

The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling

Biochemical Pharmacology ◽

10.1016/j.bcp.2020.113923 ◽

2020 ◽

Vol 175 ◽

pp. 113923 ◽

Author(s):

Wei Zhu ◽

Mei C. Li ◽

Feng R. Wang ◽

Gerardo G. Mackenzie ◽

Patricia I. Oteiza

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Growth Factor Receptor ◽

Inhibitory Effect ◽

Colorectal Cancer Cells ◽

Epidermal Growth ◽

Growth Factor Receptor Signaling

Download Full-text